Overview
PCRX market data
Price History
PCRX price chart · 1M
- O
- 26.48
- H
- 26.56
- L
- 26.31
- C
- 26.38
- Vol
- 24,141.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $26.48
- Previous Close
- $26.58
- Day High
- $26.56
- Day Low
- $26.31
- 52 Week High
- $27.66
- 52 Week Low
- $21.16
- 7 Day Return
- +2.39%
- 30 Day Return
- +6.14%
- 90 Day Return
- +15.28%
- 1 Year Return
- +20.21%
- Daily Notional Volume
- $636.7K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 71.76 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.16 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.27 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 2.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $18.80 – $27.66 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.1B · P/B 1.61 · P/S 1.41.
Company News
10 captured
Pacira BioSciences shares are trading lower after the company lowered its FY2026 sales guidance.Benzinga ·
Pacira BioSciences Q2 Adj. EPS $0.73 Beats $0.65 Estimate, Sales $192.400M Beat $190.816M EstimateBenzinga ·